Now I'm pissed! I raised cash and I went to my watch list and there is VIR... I type it in and it;s F^*865eing up 60%% I shit yoy not!!!! THIS IS WHAT I MEAN YOU HAVE TO BUY AT FIRTS BLUSH!!! FOGSKSGHSFSFMDNDIT!@#ERFGHJKL:
GBA's "2021 Stock Phantasma"
- Thread starter stonedinvestor
- Start date
Spero Therapeutics, Inc. SPRO has been struggling lately, but the selling pressure may be coming to an end soon. That is because SPRO recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
What is a Hammer Chart Pattern?
A hammer chart pattern is a popular technical indicator that is used in candlestick charting. The hammer appears when a stock tumbles during the day, but then finds strength at some point in the session to close near or above its opening price. This forms a candlestick that resembles a hammer, and it can suggest that the market has found a low point in the stock, and that better days are ahead.
Other Factors
Plus, earnings estimates have been rising for this company, even despite the sluggish trading lately. In just the past 60 days alone 1 estimate have gone higher, compared to none lower, while the consensus estimate has also moved in the right direction.
Estimates have actually risen so much that the stock now has a Zacks Rank #2 (Buy) suggesting this relatively unloved stock could be due for a breakout soon. This will be especially true if SPRO stock can build momentum from here and find a way to continue higher of off this encouraging trading development.
What is a Hammer Chart Pattern?
A hammer chart pattern is a popular technical indicator that is used in candlestick charting. The hammer appears when a stock tumbles during the day, but then finds strength at some point in the session to close near or above its opening price. This forms a candlestick that resembles a hammer, and it can suggest that the market has found a low point in the stock, and that better days are ahead.
Other Factors
Plus, earnings estimates have been rising for this company, even despite the sluggish trading lately. In just the past 60 days alone 1 estimate have gone higher, compared to none lower, while the consensus estimate has also moved in the right direction.
Estimates have actually risen so much that the stock now has a Zacks Rank #2 (Buy) suggesting this relatively unloved stock could be due for a breakout soon. This will be especially true if SPRO stock can build momentum from here and find a way to continue higher of off this encouraging trading development.
Old news but the stk has not moved yet)
Berenberg starts 'greatly underappreciated' Spero with Buy rating 12/16 SPRO Berenberg analyst Esther Hong initiated coverage of Spero Therapeutics with a Buy rating and $47 price target. The company's lead program, tebipenem HBr for the treatment of complicated urinary tract infection, allows patients to be treated completely at home versus at the hospital, Hong tells investors in a research note. The analyst believes tebipenem's differences to other antibiotics are "greatly underappreciated by the market" and support potential U.S. peak sales of $1B-plus.
Berenberg starts 'greatly underappreciated' Spero with Buy rating 12/16 SPRO Berenberg analyst Esther Hong initiated coverage of Spero Therapeutics with a Buy rating and $47 price target. The company's lead program, tebipenem HBr for the treatment of complicated urinary tract infection, allows patients to be treated completely at home versus at the hospital, Hong tells investors in a research note. The analyst believes tebipenem's differences to other antibiotics are "greatly underappreciated by the market" and support potential U.S. peak sales of $1B-plus.
Last Fri--
Spero Therapeutics price target raised to $40 from $33 at H.C. Wainwright 06:19 SPRO H.C. Wainwright analyst Raghuram Selvaraju raised the firm's price target on Spero Therapeutics to $40 from $33 and keeps a Buy rating on the shares after the United States Patent and Trademark Office issued a patent directed to a crystalline formulation of tebipenem HBr, Spero's oral carbapenem in development for the treatment of complicated urinary tract infections and acute pyelonephritis. The analyst extended the period during which he expects tebipenem to "effectively enjoy a commercial window of opportunity" in the U.S.
Spero Therapeutics price target raised to $40 from $33 at H.C. Wainwright 06:19 SPRO H.C. Wainwright analyst Raghuram Selvaraju raised the firm's price target on Spero Therapeutics to $40 from $33 and keeps a Buy rating on the shares after the United States Patent and Trademark Office issued a patent directed to a crystalline formulation of tebipenem HBr, Spero's oral carbapenem in development for the treatment of complicated urinary tract infections and acute pyelonephritis. The analyst extended the period during which he expects tebipenem to "effectively enjoy a commercial window of opportunity" in the U.S.
Hey weren't they the dry-ice play too? I forget.
Either way, yeah you kept it front and center for the last month or so.
> $2.20 = Breakout
CohBar, Inc. (CWBR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
$2.1060+0.2760 (+15.08%)<-----
CohBar, Inc. (CWBR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
$2.1060+0.2760 (+15.08%)<-----
Hey check this one out. I wrote about it yesterday in your absence. It's like Skillz, but better #'s.
Its new.
Low key.
Down today.
https://www.elitetrader.com/et/threads/playtika-holdings-corp-pltk.355180/
I will... Hey I found a nice little Pittsburg company--- The lemons to lemonade thing
Description
Limbach Holdings, Inc. provides commercial specialty contract services in the United States. It operates in two segments, Construction and Service. The company provides services in the areas of heating, ventilation, air-conditioning (HVAC), plumbing, electrical, and building controls through the design and construction of new and renovated buildings; maintenance services; and equipment upgrades. Its facility services comprise mechanical construction, HVAC service and maintenance, energy audits and retrofits, engineering and design build, constructability evaluation, equipment and materials selection, prefabrication of mechanical systems and components, and sustainable building solutions and practices. The company serves healthcare facilities; public and private colleges, universities, research centers and K-12 facilities; sports arenas; entertainment facilities, including casinos, and amusement rides; passenger terminals and maintenance facilities for rail and airports; government facilities comprising federal, state, and local agencies; hotels and resorts; office building and other commercial structures; mission critical facilities, including data centers; and industrial manufacturing facilities. It operates in Florida, California, Massachusetts, New Jersey, Pennsylvania, Delaware, Maryland, Washington DC, Virginia, West Virginia, Ohio, and Michigan. Limbach Holdings, Inc. was founded in 1901 and is headquartered in Pittsburgh, Pennsylvania.
Description
Limbach Holdings, Inc. provides commercial specialty contract services in the United States. It operates in two segments, Construction and Service. The company provides services in the areas of heating, ventilation, air-conditioning (HVAC), plumbing, electrical, and building controls through the design and construction of new and renovated buildings; maintenance services; and equipment upgrades. Its facility services comprise mechanical construction, HVAC service and maintenance, energy audits and retrofits, engineering and design build, constructability evaluation, equipment and materials selection, prefabrication of mechanical systems and components, and sustainable building solutions and practices. The company serves healthcare facilities; public and private colleges, universities, research centers and K-12 facilities; sports arenas; entertainment facilities, including casinos, and amusement rides; passenger terminals and maintenance facilities for rail and airports; government facilities comprising federal, state, and local agencies; hotels and resorts; office building and other commercial structures; mission critical facilities, including data centers; and industrial manufacturing facilities. It operates in Florida, California, Massachusetts, New Jersey, Pennsylvania, Delaware, Maryland, Washington DC, Virginia, West Virginia, Ohio, and Michigan. Limbach Holdings, Inc. was founded in 1901 and is headquartered in Pittsburgh, Pennsylvania.
It does look very close to SKillz and there was another one of these went off the other day-
Is the non sports wagering market getting crowded....